We are live on
!
Find out more
Haemonetics
180 hedge funds and large institutions have $2.21B invested in Haemonetics in 2015 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 73 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
110% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 10
7% more funds holding
Funds holding: 169 → 180 (+11)
0.45% more ownership
Funds ownership: 104.4% → 104.85% (+0.45%)
8% less capital invested
Capital invested by funds: $2.41B → $2.21B (-$201M)
14% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 73
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
180
Holders Change
+11
Holders Change %
+6.51%
% of All Funds
4.85%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
21
Increased
63
Reduced
73
Closed
10
Calls
$165K
Puts
–
Net Calls
+$165K
Net Calls Change
-$123K
Top Buyers
Top Sellers
| 1 |
PP
Prudential plc
London, England,
United Kingdom
|
-$17.3M |
| 2 |
Neuberger Berman Group
New York
|
-$15.8M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$14.2M |
| 4 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$11.1M |
| 5 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
-$9.29M |
